GeorgeCoukosMD

Clinical Trials

• DCVax-L Vaccination With CD3/CD28 Costimulated Autologous T-Cells for Recurrent Ovarian or Primary Peritoneal Cancer Start of enrollment: 2012 Jan 01

  Withdrawn

  Phase 1, Phase 2

• A Phase I Clinical Trial of Autologous Dendritic Cell Vaccine for Recurrent Ovarian or Primary Peritoneal Cancer Start of enrollment: 2007 Nov 01

  Completed

  Phase 1

• Study of Tumor Tissue Samples From Patients Who Have Undergone Surgery for Advanced Stage III or Stage IV Ovarian Epithelial Cancer Start of enrollment: 2004 Sep 01

  Recruiting

• Autologous OC-DC Vaccine in Ovarian Cancer Start of enrollment: 2010 May 01

  Completed

  Early Phase 1

• Autologous T-Cells Combined With Autologous OC-DC Vaccine in Ovarian Cancer Start of enrollment: 2011 Mar 01

  Terminated

  Phase 1

• A Clinical Trial of Autologous Oxidized Tumor Cell Lysate Vaccine For Recurrent Ovarian, Fallopian Tube or Primary Peritoneal Cancer Start of enrollment: 2011 Apr 01

  Terminated

  Phase 1, Phase 2

• Anti-programmed Cell Death-1 Ligand 1 (aPDL-1) Antibody Atezolizumab, Bevacizumab and Acetylsalicylic Acid in Recurrent Platinum Resistant Ovarian Cancer Start of enrollment: 2016 Dec 23

  Completed

  Phase 2

• TIL-ACT After NMA Chemo With IL-2 and Nivo Rescue in Metastatic Melanoma (mMEL) Start of enrollment: 2018 Feb 21

  Active, not recruiting

  Phase 1

• RACIN in Patients With Advanced TIL-negative Solid Tumors Start of enrollment: 2019 Jan 16

  Completed

  Phase 1

• Adoptive Transfer Of Autologous Tumor-Infiltrating Lymphocytes in Solid Tumors Start of enrollment: 2019 Sep 01

  Terminated

  Phase 1

• Join now to see all